Key Capital Management
PFE icon

Key Capital Management’s Pfizer PFE Stock Holding History

Key Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$371K Buy
12,665
+9,833
+347% +$262K 0.14% 104
2026
Q2 		$68.2K Sell
2,832
-936
-25% -$24.5K 0.04% 141
2026
Q1 		$106K Buy
3,768
+1,038
+38% +$27.6K 0.07% 95
2025
Q4 		$68K Buy
+2,730
New +$68.8K 0.07% 113

Other funds holding PFE

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Key Capital Management's PFE Position: Q3 2026 in Review

Key Capital Management increased its Pfizer (PFE) stake by 347% in Q3 2026, buying an estimated $262K and bringing the position to 12,665 shares worth $371K. The position accounts for 0.14% of the portfolio, ranked #104.

Key Capital Management first reported a position in PFE in Q4 2025 and has held it in 4 quarters since. 2,277 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Key Capital Management held 12,665 shares of Pfizer worth $371K as of Q3 2026.
  • Key Capital Management bought 9,833 Pfizer shares in Q3 2026, an estimated $262K.
  • Pfizer made up 0.14% of Key Capital Management's portfolio in Q3 2026, its #104 holding.
  • Key Capital Management first reported a position in Pfizer in Q4 2025 and has held it in 4 quarters since.
  • 2,277 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Key Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.